- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 104.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 111.92M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 102.32M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $59.05M |
| Capex | Q1 2026 · Mar 31, 2026 | $39.99M |
| Capex | Q1 2026 · Mar 31, 2025 | $61.96M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $46.92M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $64.09M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $608.47M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $970.65M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $311.26M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $325.11M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $741.36M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $254.48M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $360.42M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $887.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$28.69M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$210.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$202.96M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $646.97M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $619.46M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.68B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.87B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $944.29M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $426.98M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.57B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.84B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.15 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.39 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.42 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $37.64M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $32.81M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $48.83M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $39.59M |
| Net Income | Q1 2026 · Mar 31, 2026 | $15.77M |
| Net Income | Q1 2026 · Mar 31, 2025 | $38.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $36.57M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $37.64M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $144.71M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $129.44M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $113.2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $81.26M |
| Revenue | Q1 2026 · Mar 31, 2026 | $257.91M |
| Revenue | Q1 2026 · Mar 31, 2025 | $210.7M |